| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |